These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22262194)

  • 61. Impact of
    Durmanova V; Javor J; Parnicka Z; Minarik G; Ocenasova A; Vaseckova B; Reznakova V; Kralova M; Hromadka T; Shawkatova I
    Mediators Inflamm; 2021; 2021():5573642. PubMed ID: 33986628
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inherited Neuromuscular Disorders: Which Role for Serum Biomarkers?
    Lupica A; Di Stefano V; Gagliardo A; Iacono S; Pignolo A; Ferlisi S; Torrente A; Pagano S; Gangitano M; Brighina F
    Brain Sci; 2021 Mar; 11(3):. PubMed ID: 33801069
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Toxoplasma gondii infection damages the perineuronal nets in a murine model.
    Meurer YDSR; Brito RMM; da Silva VP; Andade JMA; Linhares SSG; Pereira Junior A; de Andrade-Neto VF; de Sá AL; Oliveira CBS
    Mem Inst Oswaldo Cruz; 2020; 115():e200007. PubMed ID: 32935749
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Blood substitution therapy rescues the brain of mice from ischemic damage.
    Ren X; Hu H; Farooqi I; Simpkins JW
    Nat Commun; 2020 Aug; 11(1):4078. PubMed ID: 32843630
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability.
    Takamori M
    Front Mol Neurosci; 2020; 13():86. PubMed ID: 32547365
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Repurposing of Secukinumab as Neuroprotective in Cuprizone-Induced Multiple Sclerosis Experimental Model via Inhibition of Oxidative, Inflammatory, and Neurodegenerative Signaling.
    Abdel-Maged AE; Gad AM; Rashed LA; Azab SS; Mohamed EA; Awad AS
    Mol Neurobiol; 2020 Aug; 57(8):3291-3306. PubMed ID: 32514862
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Role of Matrix Metalloproteinases (MMP-2 and MMP-9) in Ageing and Longevity: Focus on Sicilian Long-Living Individuals (LLIs).
    Cancemi P; Aiello A; Accardi G; Caldarella R; Candore G; Caruso C; Ciaccio M; Cristaldi L; Di Gaudio F; Siino V; Vasto S
    Mediators Inflamm; 2020; 2020():8635158. PubMed ID: 32454796
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Huntington's disease with comorbid myasthenia gravis: a case report.
    Chatzikonstantinou S; Dagklis I; Kazis D; Karantali E; Bostantjopoulou S
    Hippokratia; 2019; 23(1):28-29. PubMed ID: 32256036
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MMPs in learning and memory and neuropsychiatric disorders.
    Beroun A; Mitra S; Michaluk P; Pijet B; Stefaniuk M; Kaczmarek L
    Cell Mol Life Sci; 2019 Aug; 76(16):3207-3228. PubMed ID: 31172215
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Current progress in searching for clinically useful biomarkers of blood-brain barrier damage following cerebral ischemia.
    Li W; Pan R; Qi Z; Liu KJ
    Brain Circ; 2018; 4(4):145-152. PubMed ID: 30693340
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients.
    Castellazzi M; Ligi D; Contaldi E; Quartana D; Fonderico M; Borgatti L; Bellini T; Trentini A; Granieri E; Fainardi E; Mannello F; Pugliatti M
    Front Neurol; 2018; 9():1080. PubMed ID: 30619040
    [No Abstract]   [Full Text] [Related]  

  • 72. Altered S100 Calcium-Binding Protein B and Matrix Metallopeptidase 9 as Biomarkers of Mesial Temporal Lobe Epilepsy with Hippocampus Sclerosis.
    Meguid NA; Samir H; Bjørklund G; Anwar M; Hashish A; Koura F; Chirumbolo S; Hashem S; El-Bana MA; Hashem HS
    J Mol Neurosci; 2018 Dec; 66(4):482-491. PubMed ID: 30343368
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pathophysiology of Trans-Synaptic Adhesion Molecules: Implications for Epilepsy.
    Gorlewicz A; Kaczmarek L
    Front Cell Dev Biol; 2018; 6():119. PubMed ID: 30298130
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Influence of Preparation and Exposure Periods of Eluates from Ocular Prosthesis Acrylic Resin in Human Conjunctival Cell Line.
    da Silva EVF; dos Santos DM; da Rocha Bonatto L; Balera Brito VG; de Oliveira SHP; Goiato MC
    Iran Biomed J; 2019 Jan; 23(1):78-86. PubMed ID: 30011425
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intracranial Arterial Dolichoectasia.
    Del Brutto VJ; Ortiz JG; Biller J
    Front Neurol; 2017; 8():344. PubMed ID: 28769872
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal Muscles.
    Alameddine HS; Morgan JE
    J Neuromuscul Dis; 2016 Nov; 3(4):455-473. PubMed ID: 27911334
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients.
    Trentini A; Castellazzi M; Cervellati C; Manfrinato MC; Tamborino C; Hanau S; Volta CA; Baldi E; Kostic V; Drulovic J; Granieri E; Dallocchio F; Bellini T; Dujmovic I; Fainardi E
    Dis Markers; 2016; 2016():3672353. PubMed ID: 27555667
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Modulation of Matrix Metalloproteinases Activity in the Ventral Horn of the Spinal Cord Re-stores Neuroglial Synaptic Homeostasis and Neurotrophic Support following Peripheral Nerve Injury.
    Cirillo G; Colangelo AM; De Luca C; Savarese L; Barillari MR; Alberghina L; Papa M
    PLoS One; 2016; 11(3):e0152750. PubMed ID: 27028103
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Looking Inside the Matrix: Perineuronal Nets in Plasticity, Maladaptive Plasticity and Neurological Disorders.
    De Luca C; Papa M
    Neurochem Res; 2016 Jul; 41(7):1507-15. PubMed ID: 26935742
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Altered Serum Levels of Matrix Metalloproteinase-2, -9 in Response to Electroconvulsive Therapy for Mood Disorders.
    Shibasaki C; Takebayashi M; Itagaki K; Abe H; Kajitani N; Okada-Tsuchioka M; Yamawaki S
    Int J Neuropsychopharmacol; 2016 Sep; 19(9):. PubMed ID: 26912606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.